Literature DB >> 4668597

Separation of irritancy from the anti-inflammatory component of inflammation exudate.

M E Billingham, B V Robinson.   

Abstract

The anti-inflammatory component found in inflammation exudates has been purified by Sephadex gel filtration and preparative polyacrylamide electrophoresis. Highly purified material produces no greater irritancy upon injection than 0.9% sodium chloride.

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4668597      PMCID： PMC1666009          DOI： 10.1111/j.1476-5381.1972.tb07271.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN： 0007-1188            Impact factor:   8.739


  12 in total

1.  ANTIPHLOGISTIC ACTION OF GRANULOMA POUCH EXUDATES IN INTACT OR ADRENALECTOMIZED RATS.

Authors:  G DIPASQUALE; R J GIRERD; V L BEACH; B G STEINETZ
Journal:  Am J Physiol       Date:  1963-12

2.  A versatile system for preparative electrophoresis in acrylamide gel.

Authors:  A D Brownstone
Journal:  Anal Biochem       Date:  1969-01       Impact factor: 3.365

3.  Observations on the pharmacological properties of inflammatory exudate.

Authors:  D C Atkinson; A L Boura; R Hicks
Journal:  Eur J Pharmacol       Date:  1969-12       Impact factor: 4.432

4.  Suppressive effect of homologous and heterologous inflammatory exudate on tuberculin sensitivity in the guinea pig.

Authors:  J M Gaugas; M E Billingham; R J Rees
Journal:  Am Rev Respir Dis       Date:  1970-03

5.  Specific oedema-inhibiting property of a natural anti-inflammatory factor collected from inflamed tissue.

Authors:  I L Bonta; N Bhargava; C J de Vos
Journal:  Experientia       Date:  1970

6.  Role of the liver in inflammation.

Authors:  M E Billingham; A H Gordon; B V Robinson
Journal:  Nat New Biol       Date:  1971-05-05

7.  Anti-inflammatory properties of human inflammatory exudate.

Authors:  E J Billingham; B V Robinson; J M Robson
Journal:  Br Med J       Date:  1969-04-12

8.  Partial purification of the anti-inflammatory factor(s) in inflammatory exudate.

Authors:  M E Billingham; B V Robinson; J M Robson
Journal:  Br J Pharmacol       Date:  1969-03       Impact factor: 8.739

9.  Further studies on the anti-inflammatory factor found at a site of inflammation.

Authors:  B V Robinson; J M Robson
Journal:  Br J Pharmacol Chemother       Date:  1966-02

10.  Relationship between the anti-inflammatory and irritant properties of inflammatory exudate.

Authors:  D C Atkinson; R Hicks
Journal:  Br J Pharmacol       Date:  1971-03       Impact factor: 8.739
View more
  10 in total

1.  Anti-inflammatory and irritant effects of a fraction from normal human plasma.

Authors:  P N Elliott; A W Ford-Hutchinson; M J Smith
Journal:  Br J Pharmacol       Date:  1974-02       Impact factor: 8.739

Review 2.  The anti-inflammatory activity of irritants.

Authors:  D C Atkinson; R Hicks
Journal:  Agents Actions       Date:  1975-08

3.  Naturally occurring anti-inflammatory factors in the synovial fluids of patients with rheumatic disease and their possible mode of action.

Authors:  R B Capstick; D A Lewis; J A Cosh
Journal:  Ann Rheum Dis       Date:  1975-06       Impact factor: 19.103

4.  Effects of sera and exudate from carrageenan-treated rats on two models of acute inflammation.

Authors:  A D Sedgwick; M S Koh; D A Willoughby; M Pelletier
Journal:  Agents Actions       Date:  1981-11

5.  Purification and characterization of an anti-inflammatory factor (AIF) from bovine serum.

Authors:  E Misaka; K Matsuda; K Kobayashi; Y Endo; T Kojima; Y Iizuka
Journal:  Agents Actions       Date:  1978-06

6.  Inflammation, counter irritation and rat serum acute phase alpha 2-macroglobulin levels.

Authors:  B A Baldo
Journal:  Agents Actions       Date:  1982-07

7.  Anti-inflammatory action following liver damage in the rat.

Authors:  D A Lewis; D P Parrott; J Bird; R Best
Journal:  Agents Actions       Date:  1979-06

Review 8.  Intestinal immunoregulation: lessons from human mendelian diseases.

Authors:  Fabienne Charbit-Henrion; Marianna Parlato; Georgia Malamut; Frank Ruemmele; Nadine Cerf-Bensussan
Journal:  Mucosal Immunol       Date:  2021-04-15       Impact factor: 7.313

Review 9.  Rheumatological manifestations in inborn errors of immunity.

Authors:  Kaan Boztug; Seza Özen; Sevgi Köstel Bal; Julia Pazmandi
Journal:  Pediatr Res       Date:  2019-10-03       Impact factor: 3.756

10.  The paradigm of hematological malignant versus non-malignant manifestations, driven by primary immunodeficiencies: a complex interplay.

Authors:  C Kelaidi; V Tzotzola; S Polychronopoulou
Journal:  Fam Cancer       Date:  2021-06-15       Impact factor: 2.375
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.